Minorities in clinical trials
This article was originally published in The Tan Sheet
Executive Summary
Evening meeting to examine role of FDA, institutional review boards, other stakeholders "in the protection of human subjects in clinical trials as it relates to minority participation" slated for Aug. 22. Meeting will take place from 7:30 p.m.-9:30 p.m. at Meharry Medical School in Nashville, Tenn. For more information, contact FDA's Sandra Baxter at 615-781-5385...
Evening meeting to examine role of FDA, institutional review boards, other stakeholders "in the protection of human subjects in clinical trials as it relates to minority participation" slated for Aug. 22. Meeting will take place from 7:30 p.m.-9:30 p.m. at Meharry Medical School in Nashville, Tenn. For more information, contact FDA's Sandra Baxter at 615-781-5385.... |